Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruutu

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1984
[Bone marrow transplantation in leukemia and aplastic anemia: experience with 40 patients]L Volin, J Rajantie, M Perkkiö, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 1997
Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasisV J Anttila, M Färkkilä, S E Jansson, et al.
Leukemia|May 1, 2014
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysisM Stern, L C de Wreede, R Brand, et al.
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Blood|March 26, 1999
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation GroupO Ringdén, M Remberger, T Ruutu, et al.
Bone Marrow Transplantation|February 1, 1997
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT GroupT Ruutu, P Ljungman, L Brinch, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Leukemia Research|February 1, 1997
Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabineT Ruutu, A Hänninen, G Järventie, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Clinical-cytogenetic correlations in myelodysplasia (preleukemia)R V Pierre, D Catovsky, G J Mufti, et al.
Bone Marrow Transplantation|December 18, 2012
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burdenN Blijlevens, M de Château, G Krivan, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1984
[Bone marrow transplantation in leukemia and aplastic anemia: experience with 40 patients]L Volin, J Rajantie, M Perkkiö, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 1997
Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasisV J Anttila, M Färkkilä, S E Jansson, et al.
Leukemia|May 1, 2014
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysisM Stern, L C de Wreede, R Brand, et al.
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Blood|March 26, 1999
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation GroupO Ringdén, M Remberger, T Ruutu, et al.
Bone Marrow Transplantation|February 1, 1997
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT GroupT Ruutu, P Ljungman, L Brinch, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Leukemia Research|February 1, 1997
Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabineT Ruutu, A Hänninen, G Järventie, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Clinical-cytogenetic correlations in myelodysplasia (preleukemia)R V Pierre, D Catovsky, G J Mufti, et al.
Bone Marrow Transplantation|December 18, 2012
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burdenN Blijlevens, M de Château, G Krivan, et al.
Pageof 23